LifeMD (LFMD) Stock Price Target 2026

The average analyst price target for LifeMD is $10, 377.3% above the current price. Of 9 analysts, 9 rate it Buy. Targets range from $8 to $15. The latest change came on Aug 7, 2026, when HC Wainwright & Co. lowered its price target on LifeMD from $10 to $9 and kept a Buy rating.

The Average Analyst Price Target for LifeMD is $10.

Price Target Range — 12 Quarters

Analyst Consensus — 9 Analysts

9Buy

Consensus RatingBuy# Analysts9Avg. Consensus PT$10Upside to Avg. PT+377.3%

Rating Trend — Last 9 Months

Latest Upgrades and Downgrades for LifeMD Stock

See all ratings →

Date	Firm	Analyst	Action	Rating Change	Price Target
Sep 17, 2026	HC Wainwright & Co.	Yi Chen	Maintained	Buy	$9
Aug 7, 2026	HC Wainwright & Co.	Yi Chen	PT Cut	Buy	$10→$9
Aug 6, 2026	B. Riley Securities	William Woods	PT Cut	Buy	$10→$8
Aug 6, 2026	BTIG	David Larsen	PT Cut	Buy	$10→$9
May 26, 2026	HC Wainwright & Co.	Yi Chen	Maintained	Buy	$10
May 4, 2026	BTIG	David Larsen	Maintained	Buy	$10
Mar 16, 2026	Mizuho	Steven Valiquette	Upgrade	Neutral→Outperform	$6→$8
Mar 12, 2026	Freedom Broker	Ilya Zubkov	PT Raise	Buy	$8→$10
Mar 11, 2026	HC Wainwright & Co.	Yi Chen	PT Raise	Buy	$9→$10
Mar 10, 2026	BTIG	David Larsen	Maintained	Buy	$10
Nov 24, 2025	Freedom Broker	Ilya Zubkov	PT Cut	Buy	$11→$8
Nov 19, 2025	Keybanc	Scott Schoenhaus	PT Cut	Overweight	$12→$8
Nov 19, 2025	HC Wainwright & Co.	Yi Chen	PT Cut	Buy	$13→$9
Nov 19, 2025	Mizuho	Steven Valiquette	PT Cut	Neutral	$8→$6
Nov 18, 2025	Lake Street	Brooks O'Neil	PT Cut	Buy	$14→$8
Nov 18, 2025	B. Riley Securities	William Woods	PT Cut	Buy	$12→$10
Nov 18, 2025	BTIG	David Larsen	PT Cut	Buy	$18→$10
Aug 7, 2025	HC Wainwright & Co.	Yi Chen	PT Cut	Buy	$14→$13
Aug 6, 2025	Freedom Broker	Ilya Zubkov	PT Cut	Buy	$13→$11
Aug 6, 2025	Lake Street	Brooks O'Neil	PT Cut	Buy	$18→$14